News & Updation
Best Paper Awards
World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.
Best Article of current issue
Download Article : Click here
EFFECTIVE MANAGEMENT OF MENORRHAGIA WITH AN AYURVEDIC NON-HORMONAL FORMULATION ‘VEERHA’- A CLINICAL STUDY
Dr. Aarati Patil, *Dr. Kshitija Berde and Dr Priyanka Tekale
Menstruation is a crucial factor in determining women’s health. Worldwide, menstrual disturbances and associated problems are rising rapidly. Menorrhagia is a common symptom in women referring to heavy or prolonged bleeding, which arises due to various underlying disease conditions. Although various approaches to management are available, irrational selection of treatment is prevalent. The present study is an open-label, single center, non-comparative, retrospective clinical study. This study was aimed to evaluate the efficacy of a non-hormonal Ayurvedic proprietary formulation ‘Veerha’ containing ingredients like Ashoka (Saraca asoca), Lodhra (Symplocos racemosa), Musta (Cyperus rotundus), Kramuka (Areca catechu), Mocharasa (Bombax ceiba), Shatavari (Asparagus racemosus), etc. in menorrhagia. A total of 90 patients suffering from heavy, prolonged or heavy and prolonged menses falling in the age group of 21-50 years and fulfilling all the inclusion criteria were considered for the study. Patients diagnosed with serious gynecological conditions like endometriosis, adenomyosis, etc. were excluded from the study. Four tablets of Veerha (1g each) were administered daily with water for three consecutive months. The patients were followed up after completion of three months to assess amount of bleeding, period of bleeding, etc. 75.94% patients reported reduced bleeding and 55.17% patients reported shortened period length. Associated complaints like dysmenorrhea, passage of blood clots also showed significant improvement. The p value was found to be less than 0.05. The results were statistically as well as clinically significant. No adverse events or adverse drug reactions were noted during the study. All the patients tolerated the medicine well and none experienced worsening of the condition.[Full Text Article]